Syngene International Limited — Important, 13-06-2025: Updates

Syngene International has announced a board meeting to review the financial results for the quarter and half-year. The USFDA completed a Good Clinical Practices inspection at Syngene's Bengaluru facility with zero observations, underscoring the company’s strong compliance and operational standards. This enhances Syngene’s credibility and supports its growth outlook in regulated markets.